Read + Share
Amedeo Smart
Independent Medical Education
Dong T, Wu N, Gao H, Liang S, et al. CD277 agonist enhances the immunogenicity of relapsed/refractory acute myeloid leukemia towards Vdelta2(+) T cell cytotoxicity. Ann Hematol 2022 Aug 3. pii: 10.1007/s00277-022-04930.PMID: 35920929
Email
LinkedIn
Facebook
Twitter
Privacy Policy